Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Cidara Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | DEF 14A: Definitive information statements
Cidara Therapeutics | DEFA14A: Others
Cidara Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K/A: Current report (Amendment)
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | 8-K: Current report
Cidara Therapeutics | NT 10-K: Others
No Data
No Data